Last reviewed · How we verify
Prospective RandomizEd Study Comparing Glycoprotein IIb/IIIa Inhibitors VERsus Standard Therapy in PatientS with Myocardial Infarction and Angiographic Evidence of No-reFLOW (REVERSE-FLOW)
Aim of the study is to examine the effects of glycoprotein IIb/IIIa inhibitors on reperfusion success assessed by cardiac magnetic resonance imaging in patients with myocardial infarction and angiographic evidence of no-reflow.
Details
| Lead sponsor | University of Luebeck |
|---|---|
| Phase | Phase 4 |
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 120 |
| Start date | 2016-07 |
| Completion | 2025-12 |
Conditions
- Acute Myocardial Infarction
Interventions
- Glycoprotein IIb/IIIa inhibitors
Primary outcomes
- Infarct size assessed by cardiac magnetic resonance imaging — Day 1-10 after myocardial infarction
Countries
Germany